Siren

Filing Details

13F-HR/A2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-23
Total Holdings
117
Total Value
1772780355
Accession Number
0002005245-25-000008
Form Type
13F-HR/A
Manager Name
Siren
Data Enrichment
96% identified
112 identified5 unidentified

Holdings

117 positions • $1.8B total value
Manager:
Search and click to pin securities to the top
Page 1 of 6
Scholar Rock Holding Corp
Shares:9.3M
Value:$297.4M
% of Portfolio:16.8% ($297.4M/$1.8B)
07725L102
Shares:498.7K
Value:$135.7M
% of Portfolio:7.7% ($135.7M/$1.8B)
Kymera Therapeutics, Inc.
Shares:3.2M
Value:$88.7M
% of Portfolio:5.0% ($88.7M/$1.8B)
Blueprint Medicines Corp
Shares:726.2K
Value:$64.3M
% of Portfolio:3.6% ($64.3M/$1.8B)
Crinetics Pharmaceuticals, Inc.
Shares:1.7M
Value:$56.6M
% of Portfolio:3.2% ($56.6M/$1.8B)
Apellis Pharmaceuticals, Inc.
Shares:2.6M
Value:$56.4M
% of Portfolio:3.2% ($56.4M/$1.8B)
Disc Medicine, Inc.
Shares:1.1M
Value:$53.2M
% of Portfolio:3.0% ($53.2M/$1.8B)
SOLENO THERAPEUTICS INC
Shares:727.3K
Value:$52.0M
% of Portfolio:2.9% ($52.0M/$1.8B)
Ascendis Pharma A/S
Shares:287.4K
Value:$44.8M
% of Portfolio:2.5% ($44.8M/$1.8B)
Merus N.V.
Shares:1.0M
Value:$43.9M
% of Portfolio:2.5% ($43.9M/$1.8B)
Bicara Therapeutics Inc.
Shares:3.3M
Value:$42.6M
% of Portfolio:2.4% ($42.6M/$1.8B)
Centessa Pharmaceuticals plc
Shares:3.0M
Value:$42.6M
% of Portfolio:2.4% ($42.6M/$1.8B)
NewAmsterdam Pharma Co N.V.
Shares:1.9M
Value:$39.1M
% of Portfolio:2.2% ($39.1M/$1.8B)
Edgewise Therapeutics, Inc.
Shares:1.7M
Value:$37.3M
% of Portfolio:2.1% ($37.3M/$1.8B)
ARROWHEAD PHARMACEUTICALS, INC.
Shares:2.7M
Value:$34.0M
% of Portfolio:1.9% ($34.0M/$1.8B)
Avidity Biosciences, Inc.
Shares:1.1M
Value:$32.8M
% of Portfolio:1.8% ($32.8M/$1.8B)
Wave Life Sciences Ltd.
Shares:3.7M
Value:$29.9M
% of Portfolio:1.7% ($29.9M/$1.8B)
Taboola.com Ltd.
Shares:10.0M
Value:$29.4M
% of Portfolio:1.7% ($29.4M/$1.8B)
Dyne Therapeutics, Inc.
Shares:2.7M
Value:$28.4M
% of Portfolio:1.6% ($28.4M/$1.8B)
Solid Biosciences Inc.
Shares:7.4M
Value:$27.4M
% of Portfolio:1.5% ($27.4M/$1.8B)